We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
Patients requiring treatment outside of hospitals will be able to choose between multiple providers across the NHS and independent sector.
How to use a patient-reported outcomes and experiences study to evaluate your digital health product.
A new pathway supporting innovative approaches to the safe, timely and efficient development of medicines to improve patient access.
How we engage and involve patients and the public in our regulatory decision-making.
The government’s plans for the NHS and social care to deliver for patients, this winter and next.
Work is ongoing to address the comments and feedback from respondents to the consultation. Publication of our report on the consultation has been delayed in light of the Agency’s response during the ongoing coronavirus situation.
Guidance for NHS regarding disclosure to individuals holding either a Lasting Power of Attorney or a deputyship.
Information for manufacturers of medical devices about reporting adverse incidents and field safety corrective actions to the MHRA.
This toolkit is for Innovation Passport holders following the Innovative Licensing and Access Pathway (ILAP) and provides activities to support the design and development of medicines.
Information about the EU Regulations and their implementation in Northern Ireland
How the MHRA makes decisions on when a product is a medical device (borderline products), and which risk class should apply to a medical device.
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
Preventing people in England from developing high blood pressure (hypertension), and detecting and managing it better in those who have it.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).